GAO vote of confidence
This article was originally published in The Tan Sheet
Executive Summary
Two independent peer reviews give the Government Accountability Office "clean opinions" on its quality assurance system to produce congressional reports and testimony, the office announces June 30. An international peer review team led by the office of the Auditor General of Canada examined GAO's performance audit work, and the accounting firm KPMG assessed its financial audit work and attestation engagements. GAO seeks to improve the performance of the federal government. Recently, the office released a report on FDA that cites significant costs savings in the agency's risk-based approach to import safety inspections, but says the agency has yet to tighten its U.S. food supply protection (1"The Tan Sheet" June 16, 2008, p. 14)...
You may also be interested in...
FDA Right On Risk Approach, Slow On Food Protection Progress – GAO
The Government Accountability Office cites significant cost savings in its endorsement of FDA's risk-based approach to import safety inspections, but says the agency has yet to deliver on plans for tightening its protection of the U.S. food supply
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.